In the latest trading session, Astrazeneca (AZN) closed at $65.61, marking a -0.56% move from the previous day.
There is nothing like a bear market to emphasize the importance of investing in solid, reliable, and steady companies that can deliver consistent revenue and earnings for a long time. Two such companies are AstraZeneca (NASDAQ: AZN) and Visa (NYSE: V). U.K.-based AstraZeneca is a drugmaker with a vast, diversified portfolio of over three-dozen products across six major segments.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.